Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jun 18;12(9):1177–1184. doi: 10.1016/j.tranon.2019.05.004

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 The Authors

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Figure S1 — Changes in SR of tumor subtypes, as monitored during neoadjuvant chemotherapy. (A) Changes in SR of luminal subtype tumors. SRs are presented for pathologically complete responders and non–pathologically complete responders. Corresponding representative mastectomies of responders and nonresponders (not shown) demonstrate differences in the overall tumor morphology between response groups. (B) Changes in SR of basal subtype tumors, as monitored during neoadjuvant chemotherapy. SRs are presented for pathologically complete responders and non–pathologically complete responders. (C) Changes in SR of HER-2–enriched subtype tumors, as monitored during neoadjuvant chemotherapy. SRs are presented for pathologically complete responders and non–pathologically complete responders. *Statistical significance, P < .05.